Page last updated: 2024-11-03

probenecid and Viremia

probenecid has been researched along with Viremia in 2 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Viremia: The presence of viruses in the blood.

Research Excerpts

ExcerptRelevanceReference
"62 mg/kg) both without and with oral probenecid in 9 transplant patients with persistent BK viremia without nephropathy in a crossover design."3.79Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection. ( Gao, Y; Momper, JD; Randhawa, PS; Schonder, KS; Shapiro, R; Venkataramanan, R; Zhao, Y, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Momper, JD1
Zhao, Y1
Shapiro, R1
Schonder, KS1
Gao, Y1
Randhawa, PS1
Venkataramanan, R1
Chakrabarti, S1
Collingham, KE1
Osman, H1
Fegan, CD1
Milligan, DW1

Other Studies

2 other studies available for probenecid and Viremia

ArticleYear
Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:1

    Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antiviral Agents; Area Under Curve; BK Virus; Cidofovir; Cross

2013
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
    Bone marrow transplantation, 2001, Volume: 28, Issue:9

    Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytos

2001